Tuesday, November 17, 2026
Late edition · Updated as it breaks
Log inSubmit a story

“All the news worth catching.”

PaparazziPaparazzi
How to earnPaparazzi InkHolder perksLeaderboardAssignmentsContestsLeagueCity
Catcher tip lineCaught a story first? Earn stock tokens →
Sponsored
Premium projects
DEDeFadePAPackedYour project here
PaparazziPaparazzi

All the news worth catching.

Breaking news on tech, crypto, EVs, e-commerce and social the moment it breaks. Written by AI from verified reporting.

SectionsTop storiesRobinhood ChainTech & AIE-commerceWeb3 & CryptoEV & EnergyGlobal & SocialEntertainmentGamingSportsBusiness & marketsHealth & sciencePolitics & world
EarnStart hereSubmit a storyHow to earnLeaderboardContestsCatcher desksTop catchers by reputationAssignmentsCity LeagueNews bountiesCityMy catchesRewards
MarketsLive statsProof of payoutsWhale watchDeep Scan token checksStock fundToken utilityRobinhood Chain launchesRobinhood Chain projectsPremium project pagesPartnersThe Chain Weekly
PaparazziPaparazzi InkPaparazzi Ink top writersPaparazzi on TelegramHow it worksFAQProof of workAbout usHow we score trustEditorial policyPrivacy policyCorrectionsRelease notesAdvertiseContact
$PAPA contract · Robinhood Chain
© 2026 Paparazzi

Written by AI from verified reporting. Not financial advice.

  • Home
  • Submit
  • Earn
  • Sign in
Top storiesRobinhood ChainTech & AIE-commerceWeb3 & CryptoEV & EnergyGlobal & SocialEntertainmentGamingSportsBusiness & marketsHealth & sciencePolitics & worldWhales
Health & science
Important· 54

MiniMed Wins FDA Clearance for Its First Tubeless Insulin Pump

MiniMed's Fit pump just got the FDA's green light, giving the company its first tubeless option in automated insulin delivery. The device wears for up to seven days, holds 300 units and corrects glucose every five minutes. U.S. rollout starts with a phased launch in spring 2027.

By the Paparazzi desk November 16, 2026 · 7:51 AM · rttnews.com · 1 view
Fact boxTrust 50/100 · Developing
What we verified
  • Original source: rttnews.com.
  • The source published it on Nov 16, 2026 at 7:51 AM.
What we couldn't
  • No second outlet has reported it yet. Treat it as a single-source claim.

MiniMed said Monday the FDA cleared MiniMed Fit, its first tubeless insulin pump, adding a new device to its automated insulin delivery lineup. The system pairs up to seven days of wear with a 300-unit insulin capacity, smartphone app control and the company's SmartGuard technology.

MiniMed Fit is built for people with Type 1 and Type 2 diabetes aged seven and older. It adjusts insulin delivery on its own and can push correction doses every five minutes. A Meal Detection feature steps in with extra insulin when a meal dose gets skipped or comes up short.

Sponsored

Users get a choice of two sensors: Simplera Sync, rated for up to seven days of wear, and Abbott's Instinct sensor, which stretches to up to 15 days.

The company isn't rushing it to shelves. MiniMed expects a phased U.S. rollout in spring 2027, preceded by an early customer experience program planned for the fourth quarter of fiscal 2027.

Investors liked the news. MMED was trading at $18.67 on the Nasdaq, up $0.68, or 3.78 percent.

TopicsMiniMed · MMED · FDA · MiniMed Fit · SmartGuard · Simplera Sync · Abbott · Instinct

Share

Source: rttnews.com

Written by AI from verified reporting.

More stories

  • Health & science 54 minutes ago · finance.yahoo.com · 0 views
    Novartis' Cosentyx wins FDA nod as first anti-IL-17 biologic for PMR
  • Health & science 3 hours ago · casrai.org · 0 views
    FDA greenlights giredestrant-everolimus duo for ESR1-mutated breast cancer
  • Health & science 4 hours ago · nbcnews.com · Caught by @nina.anggraini29 · 0 views
    Measles Is Endemic Again as the U.S. Loses Its Elimination Status
  • Health & science 4 hours ago · aol.com · 1 view
    FDA Clears FoundationOne Liquid CDx as First Companion Test for WILSERDLY Combo
Catcher tip line

Caught a story we missed?

Log in and send it in. If it checks out, it runs with your name on it and you earn stock tokens. The bigger the story, the bigger the reward.

Submit a story
The newsletter

Get the paper in your inbox.

A short digest of the biggest news, plus optional breaking alerts. Free, no account needed.